Applications published 26 August 2009

Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
Topaz Pharmaceuticals 2091325*

Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease
Merck 2091328*

Indazole compounds
Sun, Chung-ming; Kuo, Min-liang 2091329*

Antimicrobial agent
Guggenbichler, Joseph 2091333*

Dendritic cell tumour injection therapy and related vaccine
Hasumi International Research Foundation 2091334*

Use of ex-vivo cultured hematopoietic cells for treatment of peripheral cells for treatment of peripheral vascular diseases
Gamida Cell 2091335*

Formulations comprising extracts from primitive plant species (mosses, ferns and lichens) to treat and prevent cancers
Southern Connecticut State University 2091336*

Process to form nano-sized materials, the compsns and uses thereof
Oroscience 2091505*

Oral compsn containing EGCG and lycopene
DSM IP Assets 2091506*

• Water insoluble polymer matrix for drug delivery
Alcon Research 2091514*

• Modified release analgesic suspensions
McNeil-PPC 2091515*

• Peptide nanoparticles and uses thereof
Anterios 2091516*

• Materials and methods of introducing genetic material into living cells
The University of Akron 2091517*

• Method for mixing powders
Boehringer Ingelheim Pharma 2091518*

• Multiparticulates of spray-coated drug and polymer on a meltable core
Pfizer Products 2091519*

• Oral dosage form comprising tri-substituted glycerol compounds
Alphaptose 2091520*

• Anticonvulsive pharmaceutical compsns
INSERM (Institut National de la Sante et de la Recherche Medicale) 2091521*

• Nutritional supplement compsns for treatment of ocular diseases
Novartis 2091522*

• Anandamide
DSM IP 2091523*

• Combination therapy for treating hepatitis C infections
Achillion Pharmaceuticals 2091524*

• Potentiation of cellular immunity using hitone deacetylase (HDAC) inhibitors
Sapporo Medical University 2091525*

• Treatment of pervasive developmental disorders
SHS International 2091526*

• Sulphide, sulphoxide and sulphone chalcone analogues, derivatives thereof and therapeutic uses thereof
Temple University of the Commonwealth System of Higher Education 2091527*

• Methods of inactivating viruses
Lynch, Michael; Istvan, Rudyard 2091528*

• Use of L-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases
Sigma-Tau Industrie Farmaceutiche Riunite 2091529*

• Compsns for inhibiting NADPH oxidase activity
McCarthy, Mark; Hendler, Sheldon; Rorvik, David, Inoguchi, Toyoshi 2091530*

• Phenyl substituted malemides as medicaments for blocking degenerative tissue damages by inhibiting MPT
Congenia 2091531*

• Use of indolyl-3-glycoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer
Ziopharm Oncology 2091532*

• Constrained spirocyclic compounds as CGRP receptor antagonists
Merck 2091533*

• Azetidinone derivatives and methods of use thereof
Schering 2091534*

• Use of PKC inhibitors in transplantation
Novartis 2091535*

• Enantiomeric compounds with antibacterial activity
Crestone 2091536*

• Pharmaceutical compsns for the treatment of capillary arteriopathy
ErgoNex Pharma 2091537*

• 4-benzyl-L(2H)-phthalazinones as H1 receptor antagonists
Glaxo Group 2091538*

• Ambrisentan combined with a renin inhibitor for hypertensive disorder
Gilead Colorado 2091539*

• Pyrazoloyl derivatives and therefore useful in the treatment or prophylaxis of pain
AstraZeneca 2091540*

• Vaginal delivery system for mirtazapine
NV Organon 2091541*

• Novel use of inhibitors of soluble epoxide hydrolase
F Hoffmann-La Roche 2091542*

• Complex formulation for preventing or treating osteoporosis which comprises solid dispersion of vitamin D or its derivative and bisphosphonate
Hanmi Phem 2091543*

• Compsn for the prevention and/or treatment of diseases associated with TNF and/or IL-12 overexpression
Centre National de la Recherche Scentifique (CNRS) 2091544*

• A compsn comprising the extract of combined herbs for preventing and treating liver disease
Lee, Jung Sik 2091545*

• Use of a phytosterol containing compsn for the treatment of LUTS
Natumin Pharma 2091546*

• Compsn for the treatment of gastrointestinal diseases
The University of Manchester 2091547*

• Methods for treating and reducing the incidence of newcastle disease
The Quigley Corp 2091548*

• Compsns and methods for treating infectious bronchitis
The Quigley Corp 2091549*

• Method of promoting cardiac repair using growth factors fused to heparin binding sequences
The Brigham and Women's Hospital 2091550*

• Method of diagnosing and treating asthma
Alba Therapeutics 2091551*

• Stabilised MAML peptides as uses thereof
Dana-Farber Cancer Institute; President and Fellows of Harvard College 2091552*

• Casein-derived peptides having anxiolytic activity
Institut National Polytechnique de Lorraine; Universite Henri Poincare 2091553*

• Use of polypeptides as cocciodiostat and/or histomonastat
DSM IP 2091554*

• Use of IL-27 agonists to reduce immune mediated abortion
Schering 2091555*

• G Protein coupled receptors and uses thereof
Omeros 2091556*

• Improved methods and compsns for wound healing
Coda Therapeutics 2091557*

• Methods of enhancing immune response using electroporation-assisted vaccination and boosting
Genetronics 2091558*

• Method for replicating influenza virus in culture
Schering-Plough 2091561*

• IL-8 vaccine for the treatment of various inflammatory conditions
Theravac Pharmaceuticals 2091562*

• Neutralising monoclonal antibodies against the NOGO-66 receptor (NGR) and uses thereof
Abbott Laboratories 2091563*

• Method of inhibiting coagulation with human anti-factor VA antibodies and use thereof
NovelMed Therapeutics 2091564*

• Method of diagnosing and treating glioma
Genentech 2091565*

• Combination treatments for Alzheimer's disease and similar diseases
Waratah Pharmaceuticals 2091566*

• Fusion proteins comprising an anti-inflammatory cytokine and an antigen for treatment of immune disorders
East Carolina University 2091568*

• Targeted delivery of therapeutic agents with lyophilised matrices
University of Rochester 2091569*

• New drug for treating gastric cancer
Biomerieux 2091611*

• Water-soluble prodrugs of florfenicol and its analogues
Schering-Plough 2091909*